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Background
The progressive airflow obstruction and frequent exacerbations  characteristic of 
COPD accounts for 1.4 million GP consultations annually and costs the NHS  over 
£800 million annually for emergency hospital admissions (Greener, 2011; NHS 
Medical Directorate, 2012). OPEP is an airway clearance technique which  produces  
high frequency short bursts of increased expiratory airflow to create shearing forces  
which reduce secretion viscosity and cause the airways to vibrate, aiding secretion 
mobilisation from the peripheral to the central airways (Lee et al., 2015; Barker, 
Laverty and Hopkinson, 2017). The use of OPEP to optimise mucociliary clearance 
and remove excess secretions from the airways may reduce the economic burden of 
COPD on NHS resources. Therefore, this study aimed to evaluate the effect of 
intrathoracic OPEP on clinical outcomes in stable and acute exacerbations of COPD.
Methods
A comprehensive search was undertaken (Figure 2). Inclusion criteria included an 
experimental study design of randomised controlled trials or randomised crossover 
studies, which investigated the effects of intrathoracic OPEP compared to control or 
other ACTs in adults with COPD, Chronic Bronchitis or Emphysema which were 
written in the English language. Studies which evaluated OPEP as a single treatment 











10 Figure 2: Summary of PEDro Scores
Results
A total of 322 participants from 10 studies were included. Mean PEDro score  was 6.4 (+/- 1.3) and the 
range was 5-8. Only two of the included studies investigated AECOPD. Treatment duration ranged from 
10-30 minutes per session, repeated one to four times daily, for two days to 26 weeks. OPEP was 
compared to other ACTs in five studies, usual  care in three studies and to a sham device in two studies. 
Stable COPD
HRQL
OPEP did not improve 
disease specific HRQOL 
total scores
Exacerbation Rate
OPEP did not improve 
exacerbation rate 
Sputum Volume
OPEP was equally as effective 
as other ACTS in improving 
volume of sputum expectorated
Gas Exchange
OPEP was equally as 
effective in improving Sp02 
as other ACTs
Exercise Tolerance
OPEP significantly (p<0.05) increased 6MWT 
compared to a sham device and usual care and 
significantly improved (p<0.05) exertional 
breathlessness compared to sham and autogenic 
drainage. 
Lung Function
OPEP resulted in significant improvement in FVC compared 
to sham and significantly (p=0.000) slowed deterioration in 
FEV1 when compared to usual care.
OPEP was equally effective in improving PEFR as other ACTS
Exacerbation of COPD
Gas Exchange
OPEP significantly improved ABGs 
(p<0.01) compared to usual care and 
usual care plus physiotherapy 
Use of NIV
OPEP significantly (p<0.05) reduced 
the requirement and duration of NIV 
treatment compared to usual care
Hospital Length of Stay
OPEP significantly (p<0.05) reduced  
hospital length of stay  compared to 
usual care
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37 Records included after screening of title and abstract
193 Records excluded
• 67 did not investigate COPD
• 75 did not investigate OPEP as an intervention
• 36 Study design did not meet inclusion criteria
• 5 duplicates within the same database
• 4 ongoing trials
• 6 were poster abstracts with no full publication
14 Records after duplicates removed 
4 New records identified  through citation tracking on google 
scholar (n = 3) and through hand search of reference lists (n = 1)
18 Records assessed for eligibility 
11 Records Critically Appraised 
Using PEDro score (Figure 2)
• 1 study excluded with PEDro 
score of 2
7 Records excluded 
• Inappropriate Study Design 
(3)
• Evaluated OPEP as a single 
treatment (4)
10 Records included in synthesis 
230 Records identified from Database Searching 
of MEDLINE, Academic Search Complete, CINAHL complete, 
psychINFO, SPORTdiscus, TRIP, ProQuest Central, and PubMed
Figure 1: Flow Diagram Search Strategy Undertaken
Search Terms
Chronic Obstructive Pulmonary OR Disease OR COPD OR Chronic 
Obstructive Airway Disease  OR COAD OR Chronic Bronchitis OR 
Emphysema
AND
Oscillating Positive Expiratory Pressure OR Flutter OR Acapella OR 
Cornet OR Quake OR Intrapulmonary Percussive Ventilation OR 
Intrapulmonary percussive ventilator OR VibraLung OR MetaNeb,
OR Oscillatory Positive Expiratory Pressure OR OPEP OR O-PEP OR
Iterobika OR Lung Flute OR Aerobika
Implications
Practice • Physiotherapists should continue to prescribe ACTs based on the assessment findings of 
each individual and their individual problems. Use of OPEP should be considered in 
AECOPD.
Research • A systematic review with meta-analysis is recommended conducted by experts such as the 
Cochrane Collaboration, in order to inform evidence-based practice and future policy. 
• High-quality RCTs are required to investigate  the effect of OPEP on exercise capacity as 
part of a pulmonary rehabilitation programme and to investigate the effect of OPEP in 
AECOPD managed in primary care
Policy • It is not recommended policy should change following this study, as the research question 
has not been conclusively answered as methodological quality of studies was limited, 
introducing the risk of bias and inflated treatment effects.
Conclusions
In stable COPD, OPEP is associated with an improvement in exercise capacity and lung function. In acute 
exacerbation of COPD, use of OPEP reduced the requirement and duration of NIV treatment and 
reduced hospital length of stay. 
